As of November 6, 2026, Biomea Fusion, Inc. is a publicly traded company (Nasdaq: BMEA); its largest reported holder is CVI Investments, Inc., with 9.9% on Schedule 13G/A of February 17, 2026, then Blue Owl Capital Holdings LP (5.92%) (Schedule 13G/A, February 17, 2026).
Is this your company?
About to sign with, pay or invest in Biomea Fusion, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Biomea Fusion, Inc. a real, registered company?
- Biomea Fusion, Inc. files with the SEC under CIK 1840439 (its SEC filings).
- Its shares are listed under the ticker BMEA on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in San Carlos, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Biomea Fusion, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names CVI Investments, Inc. (filed 2026-02-17).
Who are Biomea Fusion, Inc.'s owners and officers?
Biomea Fusion, Inc.: incorporated in Delaware; business address in San Carlos, California; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-02-17).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-02-17 | Cvi Investments, Inc. | 9.9% |
| Schedule 13G, 2026-02-12 | Blue Owl Capital Holdings LP | 5.92% |
| Schedule 13G/A, 2026-02-06 | Rainer M. Erdtmann | 3.9% |
| Schedule 13G, 2025-12-08 | Janus Henderson Group PLC | 5% |
| Schedule 13G/A, 2025-11-14 | Blue Owl Capital Holdings LP | 3.42% |
| Schedule 13G/A, 2025-11-07 | Cvi Investments, Inc. | 9.9% |
| Schedule 13D/A, 2025-10-24 | Cormorant Asset Management, LP | 1.53% |
| Schedule 13D/A, 2025-10-10 | Cormorant Asset Management, LP | 5.31% |
| Schedule 13G/A, 2025-08-13 | Rainer M. Erdtmann | 5.2% |
| Schedule 13G, 2025-08-11 | Blue Owl Capital Holdings LP | 6.13% |
| Schedule 13D/A, 2025-07-22 | Cormorant Asset Management, LP | 6.46% |
| Schedule 13G/A, 2025-07-16 | Blackrock, Inc. | 1.3% |
Questions about who owns Biomea Fusion, Inc.
Who owns Biomea Fusion, Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Biomea Fusion, Inc.: Cvi Investments, Inc. (9.9%, Schedule 13G/A, filed 2026-02-17), Blue Owl Capital Holdings LP (5.92%, Schedule 13G, filed 2026-02-12) and Janus Henderson Group PLC (5%, Schedule 13G, filed 2025-12-08).
Who are the largest shareholders of Biomea Fusion, Inc.?
By the share each holder's latest filing reports, the largest holders of Biomea Fusion, Inc. on this page are Cvi Investments, Inc. (9.9%), Blue Owl Capital Holdings LP (5.92%) and Janus Henderson Group PLC (5%).
When did Cvi Investments, Inc. buy into Biomea Fusion, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Cvi Investments, Inc. on this page is the Schedule 13G/A, filed 2025-11-07, reporting 9.9%; its latest, Schedule 13G/A filed 2026-02-17, reports 9.9%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Biomea Fusion, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Biomea Fusion, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Biomea Fusion, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Biomea Fusion, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Cormorant Global Healthcare Master Fund, LP: 3,570,872 shares (4.9% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2025-08-01).
- Bihua Chen: 3,570,872 shares (4.9% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2025-08-01).
- Cormorant Asset Management, LP: 3,570,872 shares (4.9% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2025-08-01).
- Cormorant Private Healthcare Fund III LP: 3,570,872 shares (4.9% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2025-08-01).
- , a director: 2,469,843 shares (3.4% of shares outstanding), 1,194,854 held directly and 1,274,989 indirectly (Form 5, 2026-02-06).
Shares outstanding: 72,483,852 as of 2026-07-31, from the company's latest SEC cover page.
How much has Biomea Fusion, Inc. raised?
No fundraising or offering filing from Biomea Fusion, Inc. is on file with us.
Keep reading
More on Biomea Fusion, Inc. and the records around it.
Biomea Fusion, Inc. elsewhere on the record
- 5%+ stake filings Feb 2026
Companies that share a holder
- Blue Owl Capital Holdings LP also filed stake reports on 10 other companies: Context Therapeutics Inc. (Aug 2026), enGene Therapeutics Inc. (Aug 2026), Aktis Oncology, Inc. (May 2026)
- Cormorant Global Healthcare Master Fund, LP also filed stake reports on 17 other companies: Corbus Pharmaceuticals Holdings, Inc. (Nov 2026), Adlai Nortye Ltd. (Aug 2026), BioAge Labs, Inc. (Aug 2026)
- CVI Investments, Inc. also filed stake reports on 48 other companies: Pine Tree Acquisition Corp. (Oct 2026), Sunshine Biopharma Inc. (Oct 2026), Outlook Therapeutics, Inc. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/biomea-fusion